HTG Molecular Diagnostics Inc (HTGMQ)

[dunkindonuts]

NEWS TODAY..Square Is One of 4 Upset Picks in Our Latest 'Sweet 16' Stock Selections
By REAL MONEY Follow | MAR 20, 2018 | 12:30 PM EDT


inShare

Email Email
Print Print
Stock quotes in this article: HTGM, MRK, ILMN, QGEN, RTEC, DECK, SQ, TWTR
Is your bracket busted after all the upsets in the first two rounds of the NCAA men's basketball tournament?

Let's pick stocks instead.

In honor of the most exciting three weeks in sports, Real Money presents its own "Sweet 16." Four great stock picks and trades each day this week from our columnists leading up to Thursday's games.

We tipped it off Monday with the "East Region."

Now we are unveiling the "South Region," with several underdog selections primed for more upsets.

James "Rev Shark" DePorre: HTG Molecular Diagnostics (HTGM)
My pick for the Real Money Sweet 16 is HTG Molecular Diagnostics, a small biotechnology company that focuses on molecular profiling and delivery mechanisms rather than in-house drug development. HTGM works with major companies like Merck (MRK) , Illumina (ILMN) and Qiagen (QGEN) .

On Jan. 4, 2018, the company issued upside guidance for the fourth quarter of 2017 of $6.9 million to $7.2 million versus guidance from two analysts of $3.45 million. It increased guidance for the entire year of 2018 to $20 million-$25 million versus analyst estimates of $13.93 million.

Technically, the chart of HTGM is developing well and I'm looking for a breakout over the $5.50 level to propel it higher.

HTGM is undersized but it should make up for its small stature with speed and flexibility. Watch for HTGM to upset some big-cap names.


https://realmoney.thestreet.com/articles/03/20/2018/square-one-4-upset-picks-our-latest-sweet-16-stock-selections?puc=cnnmoneyp&cm_ven=CNNMONEYP